InvestorsHub Logo
Followers 28
Posts 1440
Boards Moderated 0
Alias Born 12/18/2014

Re: longfellow95 post# 183417

Sunday, 07/29/2018 9:25:32 AM

Sunday, July 29, 2018 9:25:32 AM

Post# of 705611
Long, A few years ago (2015) I got into a discussion with Flip about biologics potential to have more art in their manufacturing/production. I had/have a theory about method B which is likely not patentable, but it's interesting this recent filing dances around what is not patentable in an area where they may be able to obtain IP. I have a few patents so I'll point out the filing date has less relevance in the U.S. than the rest of the world.. Rest of world is first to file U.S. Is first to practice. Meaning NWBO can obtain a patent, but if another company can document they practiced/performed what is patented before or within one year of NWBO's filing they can use the patent and not infringe. I agree with you, Koman at the time, ex and others have also made good arguments about the difficulties in obtaining IP.

That stated I'm intrigued by Doc's dd on L on what is patented "art" IMO. Perhaps the Germans view it as art too and the FDA is just a little slower in changing their view. Also noting NWBO is denying any "process improvements".

I'm here primarily for the pop-up ads I'm just that impulsive.
(Thankfully there are no such ads on the moderator screen)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News